Clinical study
Plasma norepinephrine in congestive heart failure

https://doi.org/10.1016/0002-9149(78)90162-5Get rights and content

Abstract

Resting plasma concentrations of norepinephrine, dopamine-beta-hydroxylase enzyme activity and peripheral blood lymphocyte beta adrenergic receptor sensitivity to isoproterenol as reflected in cyclic 3′,5′-adenosine monophosphate (cAMP) generation were studied in patients with congestive heart failure due to atherosclerotic heart disease or to congestive cardiomyopathy or hypertensive cardiovascular disease. Systolic time Intervals were also measured in nonhypertensive patients and correlated with the plasma norepinephrine concentration. Control patients were hospital employees without a previous history of heart disease or hypertension, and were matched for age to eliminate the effect of increasing age on the plasma norepinephrine concentration.

The results of this study clearly demonstrate that the plasma norepinephrine concentration is directly related to the degree of left ventricular dysfunction in patients with congestive heart failure. When the systolic time intervals were correlated with the plasma norepinephrine levels, a significant prolongation of the preejection period was observed with progressively increasing plasma concentrations of norepinephrine. The reverse was true for the left ventricular ejection time, which demonstrated a significant Inverse relation with the plasma norepinephrine concentration. The ratio of the preejection period to the left ventricular ejection time, which is a reflection of left ventricular function, significantly increased with increasing levels of plasma norepinephrine. In addition, plasma lymphocytes from patients with the greatest degree of left ventricular dysfunction failed to generate normal amounts of cAMP after beta adrenergic receptor stimulation with isoproterenol. It Is suggested that beta adrenergic receptors are desensitized in these patients and that this desensitization contributes to the observed alterations in myocardial contractility.

References (46)

  • LB Geffen et al.

    Synaptic vesicles in sympathetic neurons

    Physiol Rev

    (1971)
  • EH Sonnenblick

    Implication of muscle mechanics in the heart

  • RF Zelis et al.

    Control of skin and muscle circulation of forearm during leg exercise in normal subjects and patients with congestive heart failure (abstr)

    Clin Res

    (1967)
  • RS Kramer et al.

    Augmented sympathetic neurotransmitter activity in the peripheral vascular bed of patients with congestive heart failure and cardiac norepinephrine depletion

    Circulation

    (1968)
  • DT Mason et al.

    Studies on digitalis. X. Effects of ouabain on forearm vascular resistance and venous tone in normal subjects and in patients with heart failure

    J Clin Invest

    (1964)
  • JE Wood et al.

    Peripheral venoconstriction in human congestive heart failure

    Circulation

    (1956)
  • AJ Merrill

    Edema and decreased renal blood flow in patients with chronic congestive heart failure: evidence of “forward failure” as primary cause of edema

    J Clin Invest

    (1946)
  • CA Chidsey et al.

    Augmentation of the plasma norepinephrine response to exercise in patients with congestive heart failure

    N Engl J Med

    (1962)
  • JW Covell et al.

    Reduction of the cardiac response to postganglionic sympathetic nerve stimulation in experimental heart failure

    Circ Res

    (1966)
  • CA Chidsey et al.

    Myocardial norepinephrine concentration in man: effects of reserpine and of congestive heart failure

    N Engl J Med

    (1963)
  • CA Chidsey et al.

    Analysis of sympathetic activity and cardiac norepinephrine stores in congestive heart failure (abstr)

    Clin Res

    (1964)
  • GA Roblson et al.

    The catecholamines

  • CW Parker et al.

    Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma: leukocyte responsiveness to β-adrenergic agents

    J Clin Invest

    (1973)
  • Cited by (0)

    This work was supported by grants from the Michigan Heart Association, Southfield, Michigan and Grant 5 R01 HL 17555-03 from the National Institutes of Health, Bethesda, Maryland.

    View full text